{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:23:27Z","timestamp":1763389407899,"version":"3.37.3"},"reference-count":57,"publisher":"Japan Epidemiological Association","issue":"12","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2019R1G1A1004267"],"award-info":[{"award-number":["NRF-2019R1G1A1004267"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Epidemiology"],"published-print":{"date-parts":[[2021,12,5]]},"DOI":"10.2188\/jea.je20200142","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T22:11:26Z","timestamp":1612217486000},"page":"615-620","source":"Crossref","is-referenced-by-count":4,"title":["High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis"],"prefix":"10.2188","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-3235","authenticated-orcid":false,"given":"Sangjeong","family":"Ahn","sequence":"first","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Jeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Im","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungeun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjoo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Gu","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoung Wan","family":"Chae","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-8646","authenticated-orcid":false,"given":"Seungho","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"},{"name":"Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine"},{"name":"Department of Clinical Research Design &amp; Evaluation, SAIHST, Sungkyunkwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hee","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"991","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. <i>J Clin Pathol<\/i>. 2002;55:244\u2013265.","DOI":"10.1136\/jcp.55.4.244"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gustafsson L, Pont\u00e9n J, Bergstr\u00f6m R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. <i>Int J Cancer<\/i>. 1997;71:159\u2013165.","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gustafsson L, Pont\u00e9n J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. <i>Cancer Causes Control<\/i>. 1997;8:755\u2013763.","DOI":"10.1023\/A:1018435522475"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Small W Jr, Bacon MA, Bajaj A, et\u00a0al. Cervical cancer: a global health crisis. <i>Cancer<\/i>. 2017;123:2404\u20132412.","DOI":"10.1002\/cncr.30667"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Moscicki AB, Hills N, Shiboski S, et\u00a0al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. <i>JAMA<\/i>. 2001;285:2995\u20133002.","DOI":"10.1001\/jama.285.23.2995"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nash JD, Burke TW, Hoskins WJ. Biologic course of cervical human papillomavirus infection. <i>Obstet Gynecol<\/i>. 1987;69:160\u2013162.","DOI":"10.1016\/0020-7292(87)90078-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. <i>Obstet Gynecol<\/i>. 1986;67:665\u2013669.","DOI":"10.1097\/00006250-198605000-00012"},{"key":"8","unstructured":"8. Syrj\u00e4nen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. <i>Obstet Gynecol<\/i>. 1992;79:675\u2013682."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. <i>Am J Obstet Gynecol<\/i>. 2007;197:356.e1\u2013356.e16.","DOI":"10.1016\/j.ajog.2007.07.049"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ; American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. <i>Am J Obstet Gynecol<\/i>. 2003;189(1):295\u2013304.","DOI":"10.1067\/mob.2003.633"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin number 66, September 2005. Management of abnormal cervical cytology and histology. <i>Obstet Gynecol<\/i>. 2005;106(3):645\u2013664.","DOI":"10.1097\/00006250-200509000-00051"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cox JT, Schiffman M, Solomon D; ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. <i>Am J Obstet Gynecol<\/i>. 2003;188(6):1406\u20131412.","DOI":"10.1067\/mob.2003.461"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ost\u00f6r AG. Natural history of cervical intraepithelial neoplasia: a critical review. <i>Int J Gynecol Pathol<\/i>. 1993;12(2):186\u2013192.","DOI":"10.1097\/00004347-199304000-00018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schiffman M, Khan MJ, Solomon D, et\u00a0al; PEG Group; ALTS Group. A study of the impact of adding HPV types to cervical cancer screening and triage tests. <i>J Natl Cancer Inst<\/i>. 2005;97(2):147\u2013150.","DOI":"10.1093\/jnci\/dji014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de Gonz\u00e1lez A, et\u00a0al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. <i>Lancet<\/i>. 2007;370(9599):1609\u20131621.","DOI":"10.1016\/S0140-6736(07)61684-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de Gonz\u00e1lez A, et\u00a0al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. <i>Int J Cancer<\/i>. 2006;118(6):1481\u20131495.","DOI":"10.1002\/ijc.21493"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. <i>Int J Cancer<\/i>. 2006;119(5):1108\u20131124.","DOI":"10.1002\/ijc.21953"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. <i>Cell<\/i>. 2010;140:883\u2013899.","DOI":"10.1016\/j.cell.2010.01.025"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. <i>Curr Opin Genet Dev<\/i>. 2008;18:3\u201310.","DOI":"10.1016\/j.gde.2008.01.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. <i>Nature<\/i>. 2008;454:436\u2013444.","DOI":"10.1038\/nature07205"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Boccardo E, Lepique AP, Villa LL. The role of inflammation in HPV carcinogenesis. <i>Carcinogenesis<\/i>. 2010;31:1905\u20131912.","DOI":"10.1093\/carcin\/bgq176"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Parida S, Mandal M. Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention. <i>Eur J Cancer Prev<\/i>. 2014;23:432\u2013448.","DOI":"10.1097\/CEJ.0000000000000023"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Medzhitov R. Origin and physiological roles of inflammation. <i>Nature<\/i>. 2008;454:428\u2013435.","DOI":"10.1038\/nature07201"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Aran D, Lasry A, Zinger A, et\u00a0al. Widespread parainflammation in human cancer. <i>Genome Biol<\/i>. 2016;17:145.","DOI":"10.1186\/s13059-016-0995-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kemp TJ, Hildesheim A, Garc\u00eda-Pi\u00f1eres A, et\u00a0al. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. <i>Cancer Epidemiol Biomarkers Prev<\/i>. 2010;19(8):1954\u20131959.","DOI":"10.1158\/1055-9965.EPI-10-0184"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sharma A, Rajappa M, Saxena A, Sharma M. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. <i>Int J Gynecol Cancer<\/i>. 2007;17:879\u2013885.","DOI":"10.1111\/j.1525-1438.2007.00883.x"},{"key":"27","unstructured":"27. Kadish AS, Timmins P, Wang Y, et\u00a0al. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. <i>Cancer Epidemiol Biomarkers Prev<\/i>. 2002;11:483\u2013488."},{"key":"28","unstructured":"28. Hildesheim A, Schiffman MH, Tsukui T, et\u00a0al. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. <i>Cancer Epidemiol Biomarkers Prev<\/i>. 1997;6:807\u2013813."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Garc\u00eda-Pi\u00f1eres AJ, Hildesheim A, Herrero R, et\u00a0al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. <i>Cancer Res<\/i>. 2006;66(22):11070\u201311076.","DOI":"10.1158\/0008-5472.CAN-06-2034"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Trimble CL, Piantadosi S, Gravitt P, et\u00a0al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. <i>Clin Cancer Res<\/i>. 2005;11:4717\u20134723.","DOI":"10.1158\/1078-0432.CCR-04-2599"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hammes LS, Tekmal RR, Naud P, et\u00a0al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression\u2014clinicopathological correlation. <i>Gynecol Oncol<\/i>. 2007;105:157\u2013165.","DOI":"10.1016\/j.ygyno.2006.11.023"},{"key":"32","unstructured":"32. Castle PE, Hillier SL, Rabe LK, et\u00a0al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). <i>Cancer Epidemiol Biomarkers Prev<\/i>. 2001;10:1021\u20131027."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Davidson B, Goldberg I, Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. <i>Pathol Res Pract<\/i>. 1997;193:491\u2013495.","DOI":"10.1016\/S0344-0338(97)80102-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Tjiong MY, van der Vange N, ten Kate FJ, et\u00a0al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. <i>Gynecol Oncol<\/i>. 1999;73:285\u2013291.","DOI":"10.1006\/gyno.1999.5358"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et\u00a0al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. <i>Cancer Res<\/i>. 2006;66:2483\u20132487.","DOI":"10.1158\/0008-5472.CAN-05-3631"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Chiu HM, Lin JT, Chen TH, et\u00a0al. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. <i>Am J Gastroenterol<\/i>. 2008;103:2317\u20132325.","DOI":"10.1111\/j.1572-0241.2008.01952.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sasazuki S, Inoue M, Sawada N, et\u00a0al; Japan Public Health Center-Based Prospective Study Group. Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study. <i>Carcinogenesis<\/i>. 2010;31(4):712\u2013718.","DOI":"10.1093\/carcin\/bgq010"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Lee S, Choe JW, Kim HK, Sung J. High-sensitivity C-reactive protein and cancer. <i>J Epidemiol<\/i>. 2011;21:161\u2013168.","DOI":"10.2188\/jea.JE20100128"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ryu S, Chang Y, Choi Y, et\u00a0al. Age at menarche and non-alcoholic fatty liver disease. <i>J Hepatol<\/i>. 2015;62:1164\u20131170.","DOI":"10.1016\/j.jhep.2014.11.041"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Chang Y, Kim BK, Yun KE, et\u00a0al. Metabolically-healthy obesity and coronary artery calcification. <i>J Am Coll Cardiol<\/i>. 2014;63:2679\u20132686.","DOI":"10.1016\/j.jacc.2014.03.042"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kim S, Chang Y, Yun KE, et\u00a0al. Development of nephrolithiasis in asymptomatic hyperuricemia: a cohort study. <i>Am J Kidney Dis<\/i>. 2017;70:173\u2013181.","DOI":"10.1053\/j.ajkd.2017.01.053"},{"key":"42","unstructured":"42. World Health Organization, Regional Office for the Western Pacific. <i>The Asia-Pacific perspective: redefining obesity and its treatment<\/i>. Sydney: Health Communications Australia; 2000."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. <i>Stat Med<\/i>. 2002;21:2175\u20132197.","DOI":"10.1002\/sim.1203"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Newson RB. Comparing the predictive powers of survival models using Harrell\u2019s C or Somers\u2019 D. <i>Stata J<\/i>. 2010;10:339\u2013358.","DOI":"10.1177\/1536867X1001000303"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Pearson TA, Mensah GA, Alexander RW, et\u00a0al; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. <i>Circulation<\/i>. 2003;107(3):499\u2013511.","DOI":"10.1161\/01.CIR.0000052939.59093.45"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Groves IJ, Coleman N. Pathogenesis of human papillomavirus-associated mucosal disease. <i>J Pathol<\/i>. 2015;235:527\u2013538.","DOI":"10.1002\/path.4496"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Senba M, Mori N. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. <i>Oncol Rev<\/i>. 2012;6:e17.","DOI":"10.4081\/oncol.2012.e17"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Senba M, Buziba N, Mori N, et\u00a0al. Human papillomavirus infection induces NF-kappaB activation in cervical cancer: a comparison with penile cancer. <i>Oncol Lett<\/i>. 2011;2:65\u201368.","DOI":"10.3892\/ol.2010.207"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. <i>J Virol<\/i>. 2006;80:5301\u20135307.","DOI":"10.1128\/JVI.01942-05"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor\/coactivator exchange. <i>Cancer Res<\/i>. 2007;67:3976\u20133985.","DOI":"10.1158\/0008-5472.CAN-06-4273"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Sahebali S, Van den Eynden G, Murta EF, et\u00a0al. Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development. <i>Eur J Cancer Prev<\/i>. 2010;19:204\u2013215.","DOI":"10.1097\/CEJ.0b013e32833720de"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Chen Z, Ding J, Pang N, et\u00a0al. The Th17\/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. <i>Diagn Pathol<\/i>. 2013;8:61.","DOI":"10.1186\/1746-1596-8-61"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Omar T, Schwartz S, Hanrahan C, et\u00a0al. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. <i>AIDS<\/i>. 2011;25:87\u201394.","DOI":"10.1097\/QAD.0b013e328340fd99"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Shiels MS, Katki HA, Freedman ND, et\u00a0al. Cigarette smoking and variations in systemic immune and inflammation markers. <i>J Natl Cancer Inst<\/i>. 2014;106(11):dju294.","DOI":"10.1093\/jnci\/dju294"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. <i>CA Cancer J Clin<\/i>. 2018;68:394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Molokwu JC, Penaranda E, Lopez DS, Dwivedi A, Dodoo C, Shokar N. Association of metabolic syndrome and human papillomavirus infection in men and women residing in the United States. <i>Cancer Epidemiol Biomarkers Prev<\/i>. 2017;26:1321\u20131327.","DOI":"10.1158\/1055-9965.EPI-17-0129"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Huang X, Zhao Q, Yang P, et\u00a0al. Metabolic syndrome and risk of cervical human papillomavirus incident and persistent infection. <i>Medicine (Baltimore)<\/i>. 2016;95:e2905.","DOI":"10.1097\/MD.0000000000002905"}],"container-title":["Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/31\/12\/31_JE20200142\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:06:01Z","timestamp":1715144761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/31\/12\/31_JE20200142\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,5]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2188\/jea.je20200142","relation":{},"ISSN":["0917-5040","1349-9092"],"issn-type":[{"type":"print","value":"0917-5040"},{"type":"electronic","value":"1349-9092"}],"subject":[],"published":{"date-parts":[[2021,12,5]]},"article-number":"JE20200142"}}